Alexandria Hammond

Stock Analyst at B of A Securities

(1.74)
# 3,206
Out of 4,898 analysts
16
Total ratings
54.55%
Success rate
-3.85%
Average return

Stocks Rated by Alexandria Hammond

Akero Therapeutics
May 27, 2025
Maintains: Buy
Price Target: $63$64
Current: $52.72
Upside: +21.40%
Regeneron Pharmaceuticals
Nov 15, 2024
Initiates: Outperform
Price Target: $1,150
Current: $570.59
Upside: +101.55%
Pfizer
Nov 15, 2024
Initiates: Underperform
Price Target: $25
Current: $25.35
Upside: -1.38%
Moderna
Nov 15, 2024
Initiates: Underperform
Price Target: $40
Current: $32.87
Upside: +21.69%
Merck & Co.
Nov 15, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $83.67
Upside: -
Eli Lilly and Company
Nov 15, 2024
Initiates: Outperform
Price Target: $1,000
Current: $799.34
Upside: +25.10%
Johnson & Johnson
Nov 15, 2024
Initiates: Outperform
Price Target: $190
Current: $156.82
Upside: +21.16%
Gilead Sciences
Nov 15, 2024
Initiates: Outperform
Price Target: $110
Current: $112.09
Upside: -1.86%
Bristol-Myers Squibb Company
Nov 15, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $47.34
Upside: -
Biogen
Nov 15, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $133.11
Upside: -
Initiates: Outperform
Price Target: $205
Current: $191.52
Upside: +7.04%
Initiates: Underperform
Price Target: $150
Current: $318.86
Upside: -52.96%
Assumes: Buy
Price Target: $30
Current: $11.12
Upside: +169.78%